CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To address this key issue, we carried out a large methylome analysis using sorted CD34+CD15− (immature) and CD34−CD15+ (mature) cells from patients with CP‐CML at diagnosis, before any treatment and from healthy donors (HD).